Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Capillus LLC Announces 3rd FDA Cleared Laser Cap for Hair LossBy: Capillus, LLC FDA clearance for the Capillus202™ Without question, follicle shutdown plays one of the largest roles in the progression of hair loss. Stress, hormonal changes, and cellular damage are just three of the most common reasons behind hair follicle miniaturization, a phenomenon through which follicles shrink and fall into dormancy. Hair loss is known to result as follicle after follicle falls dormant and stops producing hair. Low level laser therapy (LLLT) has been shown to be beneficial in slowing the progression of hair loss by inducing phototherapy. Through consistent exposure, LLLT appears to increase blood flow to the scalp and encourages cellular respiration, thereby assisting hair follicles through the hair growth cycle. In clinical studies, Capillus laser products demonstrated an ability to increase hair count by up to 51% compared to placebo devices. Those findings are made available by ClinicalTrials.gov at the following URL: https://clinicaltrials.gov/ “At Capillus, we want to bring customers easy to use solutions that are within everyone’s budgets,” says Capillus Marketing Director, Frances Piña Brea. “Hair loss affects millions of men and women worldwide, all with unique needs and preferences. We’ve developed the Capillus202™ Preorder the Capillus202 Laser Cap This March, the Capillus202 laser cap is available for preorder on https://www.capillus.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|